Hemostemix Inc saw a remarkable increase in its stock price, gaining 15.38% in yesterday's trading session.
In a notable turn of events, Hemostemix Inc (HEM.V) experienced a significant uptick in its stock value, closing at CA$0.07. This surge marks a positive shift for the company, which has been navigating through a series of developments in the biotech sector.
Advertisement
Hemostemix Inc
HEM.V
HEM.V
Hemostemix Inc
WealthAwesomeMarket cap
$13.74M
52W high
$0.11
52W low
$0.04
1W change
+25.00%
Beta
0.73
Analyst Price Targets
Based on analyst covering HEM · as of Sep 17, 2026
Wall Street analysts forecast HEM stock price to rise 1180.0% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$0.96
+1180.0% Upside
Current Price
C$0.07
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on HEM's historical volatility
30-Day Vol
88.4%
Annualized
90-Day Vol
112.6%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$0.09
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.08 | C$0.06 – C$0.11 |
| 60 trading days | C$0.08 | C$0.05 – C$0.13 |
| 90 trading days | C$0.09 | C$0.05 – C$0.15 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: Investors should take note of Hemostemix's recent performance and ongoing strategic initiatives as potential indicators of future growth.
Hemostemix Inc's stock jumped by 15.38%
With a market cap of CA$13.74 million, Hemostemix's recent stock performance highlights its potential volatility in the small-cap biotech sector.
Bull case
The recent surge in stock price may reflect growing investor confidence, likely driven by Hemostemix's efforts to secure funding and improve its operations.
Bear case
Despite the positive movement, investors should stay cautious. The company currently has no revenue stream and limited market visibility, which could pose risks.
Recent Developments
Advertisement
Hemostemix has been active lately, announcing a non-brokered private placement aimed at raising $1,000,000, which may have contributed to the recent stock price surge. Additionally, the company has granted stock options to key personnel, showing confidence in its future prospects. For more details, visit our Hemostemix Inc stock page.
Market Performance
The 15.38% increase in Hemostemix's stock price highlights the volatility often seen in small-cap biotech companies. Investors should consider both the potential for growth and the inherent risks associated with such investments. For ongoing updates, check our Hemostemix Inc stock page.
Investor Considerations
While the recent surge is encouraging, investors are advised to conduct thorough research and stay alert to market changes. Hemostemix's lack of a revenue stream and limited coverage could impact its stock performance in the long run. For further insights, explore our Hemostemix Inc stock page.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
